Spinocerebellar Degeneration

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-06-27
Clinical Trial Update: Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration [Phase 3]
Kissei Pharmaceutical's Phase 3 confirmatory trial of KPS-0373 for spinocerebellar degeneration is currently recruiting.